UNSPSC 85721863: Revision of infusion device in right tarsal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of infusion device in right tarsal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0SWH33Z

UNSPSC 85721863 Revision of infusion device in right tarsal joint, percutaneous approach is a Commodity code with minimal relevance to state and local procurement activity. The code describes a highly specific orthopedic surgical procedure — revision of an infusion device in the tarsal joint via percutaneous approach — yet the recent opportunities posted under this code taxonomy do not reflect procurement for that service or procedure. Instead, the tagged opportunities span independent medical evaluation services for disability retirement determinations, Centers of Excellence networks for surgical carve-outs under employee health plans, occupational medical surveillance for transportation workers, emergency and specialty medical care for youth in detention, pharmacy benefit management administration, and temporary ancillary health professional staffing. None of these services involve tarsal joint device revision or percutaneous orthopedic procedures. The mismatch suggests either a coding error in how state and local procurement offices have tagged these opportunities or a fundamental misalignment between the UNSPSC category definition and the work actually being bought under this code number.

The recent opportunities do reflect genuine state and local healthcare procurement activity across multiple issuing bodies — a city pension board, a city health benefits office, a state transportation agency, a county juvenile probation department, a county government, and a county health system — posted between July and September 2026 with response deadlines between September and October 2026. However, because these opportunities do not align with the code's stated scope of tarsal joint device revision, they do not provide actionable intelligence for vendors offering orthopedic implants, device-revision services, or related clinical capabilities. A business development professional evaluating this code should treat it as carrying no meaningful recent procurement signal in its current state and seek clarification on the coding taxonomy or consider whether a different UNSPSC code more accurately captures the orthopedic implant or procedure revision market state and local governments are actually buying.